miR-4516 is a Novel Prognostic Biomarker and Promotes Tumorigenesis via Targeting PTPN14-Mediated Regulation of the Hippo Pathway in Glioblastoma

T. Cui; E. H. Bell; J. McElroy; A. Becker; P. Gulati; M. Geurts; N. Mladkova; A. Gray; K. Liu; L. Yang; Z. Liu; J. Fleming; S. J. Haque; P. Robe; A. Chakravarti

doi:10.1016/j.ijrobp.2018.07.656

miR-4516 is a Novel Prognostic Biomarker and Promotes Tumorigenesis via Targeting PTPN14-Mediated Regulation of the Hippo Pathway in Glioblastoma

T. Cui
, E. H. Bell
, J. McElroy
, A. Becker
, P. Gulati
, M. Geurts
, N. Mladkova
, A. Gray
, K. Liu
, L. Yang
, Z. Liu
, J. Fleming
, S. J. Haque
, P. Robe
, A. Chakravarti

Research output: Contribution to journal › Meeting Abstract › Academic

Original language	English
Pages (from-to)	e176-e177
Journal	International Journal of Radiation Oncology Biology Physics
Volume	102
Issue number	3, Supplement
DOIs	https://doi.org/10.1016/j.ijrobp.2018.07.656
Publication status	Published - 1 Nov 2018

Access to Document

10.1016/j.ijrobp.2018.07.656

1-s2.0-S0360301618321102-mainFinal published version, 387 KBLicence: Taverne

Cite this

Cui, T., Bell, E. H., McElroy, J., Becker, A., Gulati, P., Geurts, M., Mladkova, N., Gray, A., Liu, K., Yang, L., Liu, Z., Fleming, J., Haque, S. J., Robe, P., & Chakravarti, A. (2018). miR-4516 is a Novel Prognostic Biomarker and Promotes Tumorigenesis via Targeting PTPN14-Mediated Regulation of the Hippo Pathway in Glioblastoma. International Journal of Radiation Oncology Biology Physics, 102(3, Supplement), e176-e177. https://doi.org/10.1016/j.ijrobp.2018.07.656

@article{3ae4964806c041f5bca5e1140405072c,

title = "miR-4516 is a Novel Prognostic Biomarker and Promotes Tumorigenesis via Targeting PTPN14-Mediated Regulation of the Hippo Pathway in Glioblastoma",

author = "T. Cui and Bell, \{E. H.\} and J. McElroy and A. Becker and P. Gulati and M. Geurts and N. Mladkova and A. Gray and K. Liu and L. Yang and Z. Liu and J. Fleming and Haque, \{S. J.\} and P. Robe and A. Chakravarti",

year = "2018",

month = nov,

day = "1",

doi = "10.1016/j.ijrobp.2018.07.656",

language = "English",

volume = "102",

pages = "e176--e177",

journal = "International Journal of Radiation Oncology Biology Physics",

issn = "0360-3016",

publisher = "Elsevier",

number = "3, Supplement",

}

Cui, T, Bell, EH, McElroy, J, Becker, A, Gulati, P, Geurts, M, Mladkova, N, Gray, A, Liu, K, Yang, L, Liu, Z, Fleming, J, Haque, SJ, Robe, P & Chakravarti, A 2018, 'miR-4516 is a Novel Prognostic Biomarker and Promotes Tumorigenesis via Targeting PTPN14-Mediated Regulation of the Hippo Pathway in Glioblastoma', International Journal of Radiation Oncology Biology Physics, vol. 102, no. 3, Supplement, pp. e176-e177. https://doi.org/10.1016/j.ijrobp.2018.07.656

miR-4516 is a Novel Prognostic Biomarker and Promotes Tumorigenesis via Targeting PTPN14-Mediated Regulation of the Hippo Pathway in Glioblastoma. / Cui, T.; Bell, E. H.; McElroy, J. et al.
In: International Journal of Radiation Oncology Biology Physics, Vol. 102, No. 3, Supplement, 01.11.2018, p. e176-e177.

Research output: Contribution to journal › Meeting Abstract › Academic

TY - JOUR

T1 - miR-4516 is a Novel Prognostic Biomarker and Promotes Tumorigenesis via Targeting PTPN14-Mediated Regulation of the Hippo Pathway in Glioblastoma

AU - Cui, T.

AU - Bell, E. H.

AU - McElroy, J.

AU - Becker, A.

AU - Gulati, P.

AU - Geurts, M.

AU - Mladkova, N.

AU - Gray, A.

AU - Liu, K.

AU - Yang, L.

AU - Liu, Z.

AU - Fleming, J.

AU - Haque, S. J.

AU - Robe, P.

AU - Chakravarti, A.

PY - 2018/11/1

Y1 - 2018/11/1

U2 - 10.1016/j.ijrobp.2018.07.656

DO - 10.1016/j.ijrobp.2018.07.656

M3 - Meeting Abstract

SN - 0360-3016

VL - 102

SP - e176-e177

JO - International Journal of Radiation Oncology Biology Physics

JF - International Journal of Radiation Oncology Biology Physics

IS - 3, Supplement

ER -